TherapySelector vs endlink® Secure Messenger
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
TherapySelector
This app assists physicians in selecting personalized treatment plans for hypertension and hepatitis C. It analyzes patient data to provide information on medication effectiveness, adverse events, and costs, supporting informed decisions during consultations.
- Patient profile determination based on 4 questions
- Medication effectiveness and adverse event probability
- Treatment cost information
- Hypertension therapy options (THZ, CCA, ACEi, ARB)
- Monotherapy and stepwise addition guidance
- Available in English and Dutch
Read full descriptionHide full description
TherapySelector supports you as a physician to easily and quickly choose a data-based, person-centered treatment for hypertension and hepatitis C for and with your patient during consultation hours. The app shows in a single glance information about the effectiveness of medication based on the disease remission (systolic blood pressure lower than 140 mmHg for hypertension and viral clearance in hepatitis C), the likelihood of adverse events, cost and patient group size. This overview allows you to easily and quickly decide on the best person-centered treatment method for your patient, based on study data. How does TherapySelector work? First you enter the requested characteristics of your patient by answering 4 simple questions about etiology, disease stage, previous treatments and comorbidities. Based on this, a profile of the patient is determined. The app then shows an overview of all registered treatments for that specific patient profile, based on frequently updated study results. For each therapy you find information about effectiveness, possible adverse events and costs. TherapySelector currently provides the following features: • Determination of patient profiles based on four simple questions about the patient. • Probability of "success" of all registered medication (combinations) for hypertension and hepatitis C, together with the probability of adverse events associated with the patient profile, based on individual patient data from key clinical scientific studies. • For hypertension: overview of therapy options with Thiazide diuretics (THZ), Calcium Channel Blockers (CCA), ACE inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB). Information on monotherapy with dose increase (Titrate), and results of stepwise addition of medication (Titrate & Add). • Detail information, including information about dosage (of the therapy regime) and the cost of a specific treatment. • Availability in both English and Dutch. TherapySelector is intended to provide physicians and patients person-centered information to support them in choosing the most appropriate treatment. In doing so, the app complements guidelines that are based on the ‘average’ patient. The TherapySelector app can be used without creating an account. Developed with (academic) medical centers and research institutes TherapySelector is developed by TherapySelector in collaboration with physicians and scientists associated with universities and leading academic medical centers such as the Erasmus MC, LUMC and MUMC+. The data in the app has been authorized by specialists from Dutch scientific associations. The results are calculated using anonymous patient data from scientific studies of published randomized controlled trials, other phase 2 & 3 studies and prospective real-life studies around the world (high quality research). Research groups and sponsors make their data available for this purpose. About TherapySelector TherapySelector B.V. is a social enterprise. Our mission is to improve health care globally by enriching it with person-centered treatment information based on the most recent data from scientific studies. It is not our goal to make profit. With the TherapySelector app, we facilitate doctors with person-centered care to achieve health gains for their patients. Additionally, we want to aid in controlling the rising costs of healthcare for the public, e.g. by preventing over- and under-treatment. Follow us on LinkedIn (https://www.linkedin.com/company/therapyselector) or visit www.therapyselector.com.
endlink® Secure Messenger
This secure messaging app provides HIPAA-compliant communication for organizations, especially in healthcare. It offers AI-assisted message features, easy onboarding, and robust security to protect sensitive information.
- AI-assisted message generation, replies, and editing
- HIPAA security and privacy standards
- Easy self-onboarding
- Message and media transmission
- Message prioritization and categorization
- Message-to-task conversion
- Mass communication and group sorting
- On-call scheduling with notifications
Read full descriptionHide full description
Every organization needs a secure texting and communication management solution. In the healthcare industry, in particular, workers want a quick and easy way to communicate with their peers, but medical practices need to ensure HIPAA compliance when workers send messages containing Protected Health Information. Enter endlink®. Here are a few of endlink®’s simple, but robust features. More are coming soon! • The first tool of its type to offer AI-assisted message generation, replies, and editing. • Security powerful enough to meet HIPAA’s security and privacy standards (perfect for medical and a great fit for any other industry) • Easy self-onboarding • Message and media transmission as easy to use as any ordinary text messenger • Message prioritization and automatic categorization • Message-to-actionable task conversion • Mass communication via sorting users into groups or locations • On Call scheduling with escalated SMS/voice notifications • Permission controls to determine who has access to what information • Data stored solely in a secure environment, not on users’ mobile devices, so that terminated employees do not have access to secure information • Interaction with the endlink® web client • Scalability, allowing organizations of any size to make use of endlink®’s features
Screenshots
Verdict
The clearest difference is rating: endlink® Secure Messenger at 5.0 against TherapySelector's 3.0. endlink® Secure Messenger also leads on update cadence (fortnightly vs every 3 months). TherapySelector's advantage is iOS requirement (12.0 vs 15.1). On price, ratings volume, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
endlink® Secure Messenger holds the better App Store score, 5.0 against 3.0. Both are backed by a comparable volume of ratings — 2 and 5 respectively.
TherapySelector ships an update every 3 months, endlink® Secure Messenger fortnightly. The most recent releases landed on July 4, 2026 and September 10, 2026 respectively.
| Parameter | TherapySelector | endlink® Secure Messenger |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (2 ratings) | 5.0 (5 ratings) — better |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | 2 | 5 — better |
| Update frequency | Every 3 months | Fortnightly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 26 MB | 113 MB |
| Age rating | 17+ | 4+ |
| Developer | TherapySelector B.V. | Endlink |
Customer experience
TherapySelector
endlink® Secure Messenger
In-app purchases
TherapySelector
No in-app purchases
endlink® Secure Messenger
No in-app purchases
Questions
Is TherapySelector free?
Is endlink® Secure Messenger free?
Which has better reviews, TherapySelector or endlink® Secure Messenger?
Do TherapySelector or endlink® Secure Messenger have ads?
Which is updated more often, TherapySelector or endlink® Secure Messenger?
Other comparisons















